C07D 239/96
Two oxygen atoms
C07D239/96 (Two oxygen atoms) appears on 275 US grants and 197 published applications in this corpus.
Search patents in C07D- Granted patents
- 275
- Published applications
- 197
- Assignees
- 165
- Inventors
- 1,001
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 5 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 6 | 0 |
| 1987 | 9 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 14 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 11 | 2 |
| 2002 | 13 | 10 |
| 2003 | 7 | 7 |
| 2004 | 6 | 14 |
| 2005 | 7 | 14 |
| 2006 | 9 | 13 |
| 2007 | 8 | 9 |
| 2008 | 3 | 10 |
| 2009 | 9 | 4 |
| 2010 | 9 | 12 |
| 2011 | 11 | 7 |
| 2012 | 7 | 6 |
| 2013 | 7 | 9 |
| 2014 | 6 | 8 |
| 2015 | 5 | 2 |
| 2016 | 4 | 8 |
| 2017 | 6 | 4 |
| 2018 | 2 | 5 |
| 2019 | 4 | 5 |
| 2020 | 3 | 6 |
| 2021 | 4 | 5 |
| 2022 | 4 | 6 |
| 2023 | 4 | 11 |
| 2024 | 2 | 4 |
| 2025 | 3 | 10 |
| 2026 | 8 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Composition for use in the treatment of ApoL1-associated disease19 May 2026US 12,629,376 B2Vertex Pharmaceuticals Incorporated
- Compositions, formulations, and methods for skin treatment3 Mar 2026US 12,564,547 B2Oddity Labs, LLC
- Quinazolinone dione compounds and uses thereof24 Feb 2026US 12,559,464 B2Edgewise Therapeutics, Inc.
- Quinazolinone dione compounds and uses thereof3 Sep 2026US 2026/0258001 A1Edgewise Therapeutics, Inc.
- Benzopyrimidin-4(3h)-ones as pi3k inhibitors20 Aug 2026US 2026/0242398 A1OnKure, Inc.
- 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors30 Jul 2026US 2026/0217709 A1Ideaya Biosciences, Inc.
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Hsd17b13 inhibitors and uses thereof9 Jul 2026US 2026/0193218 A1Inipharm, Inc.
Most cited
By later US patents
- Compounds for inhibition of ceramide-mediated signal transduction117US 6,323,201 B1The Regents of the University of California · 2001
- Benzimidazoles for ischemic heart conditions96US 5,693,652 AEisai Co., Ltd. · 1997
- Compounds for inhibition of ceramide-mediated signal transduction96US 6,562,819 B2The Regents of the University of California · 2003
- Piperidinylalkyl quinazoline compounds, composition and method of use85US 4,335,127 AJanssen Pharmaceutica NV · 1982
- 5-fluoroanthranilic fungicides76US 5,093,364 ASchering Agrochemicals Limited · 1992